Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics and Safety Studies of Esomeprazole Use in Schizophrenic Patients

NCT03333603 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT03333603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03333603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics and Safety Studies of Esomeprazole Use in Schizophrenic Patients
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 23, 2016
Completion date
January 23, 2017
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia